Gastric carcinoma
MONDO:0004950A carcinoma that arises from epithelial cells of the stomach.
Also known as: cancer of stomach, cancer of the stomach, gastric (stomach) cancer, gastric cancer, gastric cancer, NOS, stomach cancer, carcinoma of stomach, carcinoma of the stomach
3389 clinical trials for this condition and its sub-types, 92 tagged with Gastric carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Gastric carcinoma
-
Gastric adenocarcinoma 449 trials · 481 incl. sub-types
9 sub-types
- Microinvasive gastric cancer 28 trials
- Diffuse gastric adenocarcinoma 1 trial · 5 incl. sub-types Sub-types →
- Gastric cardia adenocarcinoma 4 trials
- Signet ring cell gastric adenocarcinoma 2 trials
- CTNNA1-related diffuse gastric and lobular breast cancer syndrome 0 trials
- Gastric intestinal type adenocarcinoma 0 trials
- Gastric papillary adenocarcinoma 0 trials
- Gastric tubular adenocarcinoma 0 trials
- Mucinous gastric adenocarcinoma 0 trials
-
Gastric cardia carcinoma 3 trials · 7 incl. sub-types
2 sub-types
- Gastric cardia adenocarcinoma 4 trials
- Carcinoma in situ of gastric cardia 0 trials
-
Hereditary gastric cancer 1 trial · 6 incl. sub-types
-
Gastric squamous cell carcinoma 4 trials
1 sub-type
- Gastric adenosquamous carcinoma 0 trials
-
Stomach carcinoma in situ 4 trials
3 sub-types
- Carcinoma in situ of fundus of stomach 0 trials
- Carcinoma in situ of gastric body 0 trials
- Carcinoma in situ of gastric cardia 0 trials
-
Gastric body carcinoma 1 trial
1 sub-type
- Carcinoma in situ of gastric body 0 trials
-
Gastric fundus carcinoma 0 trials
1 sub-type
-
Gastric pylorus carcinoma 0 trials
Most studied deeper sub-types
-
New drug cocktail aims to make inoperable abdominal cancers operable
Disease control CompletedThis phase 2 trial tested a combination of two drugs—paclitaxel (given intravenously and directly into the abdomen) and oral nilotinib—in 21 adults with cancers that had spread to the lining of the abdomen and could not be surgically removed. The goal was to see if the treatment …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New stomach cancer surgery technique shows promise in early trial
Disease control CompletedThis study tested a new way to reconnect the stomach and small intestine after removing the lower part of the stomach in people with advanced stomach cancer. The goal was to see if the new stapling method was safe and worked well. One hundred patients took part, and the researche…
Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Tailored immunotherapy cocktail shows promise for tough stomach cancer
Disease control CompletedThis phase 2 trial tested personalized immunotherapy combinations for advanced gastric cancer that had worsened after initial chemotherapy. Researchers matched treatments to tumor genetics: patients with certain genetic features received atezolizumab plus ipatasertib, while other…
Phase 2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for Hard-to-Treat cancers? utidelone trial underway
Disease control CompletedThis phase 2 trial tests the drug utidelone in 126 people with advanced solid tumors (excluding breast, lung, and colorectal cancers) that have not responded to standard treatments. The study aims to see if the drug can shrink tumors and how safe it is. Participants receive utide…
Phase 2 • Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug combo shows promise for tough stomach cancers
Disease control CompletedThis study tested two drugs, olaparib and ramucirumab, in 51 people with advanced stomach or gastroesophageal junction cancer that had spread or could not be removed. The goal was to find the best dose and see how well the combination worked. The trial is complete, and results ma…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
First human trial of BI 765049 combo aims to fight hard-to-treat cancers
Disease control CompletedThis early-phase study tests two experimental drugs, BI 765049 and ezabenlimab, in adults with advanced solid tumors like colorectal, lung, and pancreatic cancer. The main goal is to find the highest safe dose of BI 765049 alone and in combination with ezabenlimab. Participants r…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can acupuncture and ice chips beat chemo nerve damage?
Symptom relief CompletedThis phase 2 trial looked at whether adding acupuncture and acupressure to oral cryotherapy (sucking on ice chips) can reduce nerve pain caused by oxaliplatin chemotherapy in people with gastrointestinal cancers. 78 patients were split into two groups: one got cryotherapy alone, …
Phase 2 • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Zinc may boost quality of life for advanced cancer patients on chemo
Symptom relief CompletedThis study looked at whether taking zinc supplements can improve quality of life for people with advanced gastrointestinal cancers (like stomach, liver, or pancreatic cancer) who are receiving chemotherapy. Seventeen patients participated, and researchers measured their quality o…
Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Smart devices track cancer recovery at home
Knowledge-focused CompletedThis study tested whether using at-home monitoring devices (like a wristband pedometer, scale, and blood pressure cuff) can help improve care for cancer patients after they leave the hospital following surgery. 22 patients with various cancers participated. The goal was to see if…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC